Skip to main content
iconarzneimittelforschung.de

iconarzneimittelforschung.de

https://iconarzneimittelforschung.de

L-aħħar skennjat October 1, 2026

Skennjar tal-cookies ta' iconarzneimittelforschung.de esegwit fi October 1, 2026 sab 3 cookies u 18 talbiet ta' traċċar minn partijiet terzi. Il-valutazzjoni kopriet 10 paġni fi 10 templates ta' paġni uniċi. Is-sit jimpjega OneTrust bħala l-pjattaforma tiegħu għall-ġestjoni tal-kunsens. La IAB TCF v2.3 u lanqas Google Consent Mode v2 ma ġew osservati fil-verifika tagħna. Instab 18 talbiet ta' partijiet terzi minn 8 fornituri.

Cookies

3

Ta' partijiet terzi

0

Trackers

18

Fornituri

8

Banner tal-kunsens

OneTrust

Skennjar

1

X'jonqos minn din il-konfigurazzjoni

  • Ġew osservati tags ta' Google, iżda Google Consent Mode v2 ma ġiex identifikat.

Konformità skont l-udjenza

L-Unjoni Ewropea

✗ Mhux issodisfat

GDPR + ePrivacy · Kunsens minn qabel (opt-in)

Ir-Renju Unit

✗ Mhux issodisfat

UK GDPR + PECR · Ibbażat fuq il-kunsens

L-Istati Uniti

✓ Jissodisfa dan il-mudell

CCPA/CPRA + state laws · Avviż u opt-out

Il-Kanada

! Jeħtieġ attenzjoni

PIPEDA + Québec Law 25 · Ibbażat fuq il-kunsens

Il-Brażil

! Jeħtieġ attenzjoni

LGPD · Ibbażat fuq il-kunsens

Skennjat mill-UE; is-siti jistgħu juru banners jew traċċar differenti lil reġjuni oħra. Il-verdetti jirriflettu l-imġiba osservata mkejla skont ir-regoli ta' kull udjenza.

Sigurtà tal-konnessjoni

HTTPS appoġġjat

✓

Jidderieġi HTTP għal HTTPS

✓

HSTS

✓

Content Security Policy

✓

Cookies

3 cookies misjuba: 2 meħtieġa, 0 analitiċi, 1 marketing

Total

3

Neċessarji

2

Funzjonali

0

Analitika

0

Marketing

1

Mhux magħruf

0

Iffiltra skont il-kategorija
Isem Dominju Kategorija Fornitur Skadenza Sigur HttpOnly Parti
BCSessionID qabel il-kunsens .iconarzneimittelforschung.de Marketing Blueconic.com 1.1 yr ħajja ta' aktar minn 13-il xahar ✓ – 1st
OptanonConsent .iconarzneimittelforschung.de Necessary OneTrust 180 d – – 1st
PHPSESSID www.iconarzneimittelforschung.de Necessary PHP Skadut ✓ ✓ 1st

Ħażna tal-browser issettjata mis-sit

Isem Dominju Parti
bc_local_storage_check issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:37:219 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883549291 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883549292 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
sessionStartTime issettjata minn www.iconarzneimittelforschung.de/gtm.js https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
pageCount issettjata minn www.iconarzneimittelforschung.de/gtm.js https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCZoneID issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:147:70 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883549625 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883549626 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883549628 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883549629 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883549634 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883554067 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883554068 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883554502 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883554503 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883554505 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883554506 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883554509 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883554188 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883554189 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883554599 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883554600 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883554602 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883554604 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883554607 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883553910 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883553911 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883554396 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883554397 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883554399 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883554400 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883554404 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883556816 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883556817 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883557031 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883557032 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883557034 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883557014 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883557015 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883557215 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883557216 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883557218 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883558135 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883558136 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883558294 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883558296 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883558298 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883559551 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883559552 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883559748 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883559749 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883559751 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883560819 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883560820 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883561066 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883561067 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883561069 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883561892 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883561893 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883562148 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883562149 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883562151 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
_grecaptcha issettjata minn www.gstatic.com/recaptcha__nl.js:683:123 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883563822 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883563823 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883564040 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883564041 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens
BCRevision_1790883564043 issettjata minn e001.geneesmiddelenonderzoek.nl/script.js:161:468 https://www.iconarzneimittelforschung.de 1st qabel il-kunsens

Trackers ta' partijiet terzi

18 talbiet misjuba minn 8 fornituri: BlueConic, Google LLC, New Relic, Meta Platforms, Inc., Microsoft...

Analytics

4

Marketing

4

Necessary

6

Functional

1

Other

3

Fornitur Kategorija Tip Dominju
BlueConic qabel il-kunsens BlueConic tracker domain (source: Disconnect.me, category: Analytics) Analytics script geneesmiddelenonderzoek.blueconic.net
Google LLC qabel il-kunsens Google Tag Manager Analytics script www.googletagmanager.com
New Relic qabel il-kunsens New Relic tracker domain (source: Disconnect.me, category: Analytics) Analytics script js-agent.newrelic.com
New Relic qabel il-kunsens New Relic tracker domain (source: Disconnect.me, category: Analytics) Analytics script bam.eu01.nr-data.net
Google LLC qabel il-kunsens Google reCAPTCHA bot protection Functional script www.google.com
Google LLC qabel il-kunsens YouTube embedded video Marketing iframe www.youtube.com
Meta Platforms, Inc. qabel il-kunsens Facebook SDK / Pixel Marketing script connect.facebook.net
Microsoft qabel il-kunsens Microsoft tracker domain (source: Disconnect.me, category: Advertising) Marketing pixel bat.bing.com
Microsoft Advertising qabel il-kunsens Microsoft Advertising (Bing Ads) UET tag: conversion tracking and remarketing Marketing script bat.bing.net
Google LLC Google Fonts stylesheet Necessary script fonts.googleapis.com
Google LLC Google Fonts files Necessary script fonts.gstatic.com
Google LLC Google tracker domain (source: Disconnect.me, category: Content) Necessary script i.ytimg.com
Google LLC Google tracker domain (source: Disconnect.me, category: Content) Necessary script www.gstatic.com
Google LLC Google tracker domain (source: Disconnect.me, category: Content) Necessary script jnn-pa.googleapis.com
OneTrust LLC OneTrust consent management Necessary script cdn.cookielaw.org
Google LLC qabel il-kunsens Google tracker domain (source: Disconnect.me, category: FingerprintingGeneral) Unknown script pagead2.googlesyndication.com
Google LLC qabel il-kunsens Google tracker domain (source: Disconnect.me, category: FingerprintingGeneral) Unknown script googleads.g.doubleclick.net
OneTrust OneTrust tracker domain (source: Disconnect.me, category: ConsentManagers) Unknown script geolocation.onetrust.com

Storja tal-iskennjar

Skennjar wieħed komplut: cookies u trackers mill-iskennjar fi October 1, 2026.

Skennjar riċenti

October 1, 2026 3 18

iconarzneimittelforschung.de huwa l-websajt tiegħek?

Ikklejmjah biex timmonitorja l-cookies u t-trackers tiegħek, tissettja banner tal-kunsens konformi b'imblukkar awtomatiku tal-iskripts, u żżomm il-politika tal-cookies tiegħek aġġornata.